Xiangxue Pharmaceutical (300147) — Free Cash Flow Generation Index
Xiangxue Pharmaceutical (300147) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of CN¥69.90 Million represents 1% of operating cash flow (CN¥75.64 Million). Read debt load of Xiangxue Pharmaceutical for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xiangxue Pharmaceutical Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Xiangxue Pharmaceutical across 19 annual periods. Explore 300147 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Xiangxue Pharmaceutical (2007–2025)
Year-by-year Free Cash Flow Generation Index for Xiangxue Pharmaceutical. For the full company profile including market capitalisation, see Xiangxue Pharmaceutical market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥118.12 Million | CN¥139.63 Million | CN¥21.51 Million | ▲ +190.1% |
| 2024 | -0.94x | CN¥-17.07 Million | CN¥18.17 Million | CN¥35.24 Million | ▼ -219.3% |
| 2023 | 0.79x | CN¥207.41 Million | CN¥263.44 Million | CN¥56.03 Million | ▲ +228.0% |
| 2022 | -0.62x | CN¥-139.89 Million | CN¥227.38 Million | CN¥367.27 Million | ▲ +48.1% |
| 2021 | -1.18x | CN¥-305.18 Million | CN¥257.56 Million | CN¥562.74 Million | ▲ +32.3% |
| 2020 | -1.75x | CN¥-450.24 Million | CN¥257.18 Million | CN¥707.42 Million | ▲ +74.9% |
| 2019 | -6.96x | CN¥-578.07 Million | CN¥83.02 Million | CN¥661.09 Million | ▼ -57.2% |
| 2018 | -4.43x | CN¥-404.23 Million | CN¥91.24 Million | CN¥495.46 Million | ▲ +27.4% |
| 2017 | -6.10x | CN¥-668.33 Million | CN¥109.53 Million | CN¥777.87 Million | ▲ +31.5% |
| 2016 | -8.91x | CN¥-1.77 Billion | CN¥198.48 Million | CN¥1.97 Billion | ▼ -1116.4% |
| 2015 | -0.73x | CN¥-117.06 Million | CN¥159.89 Million | CN¥276.95 Million | ▼ -54.9% |
| 2014 | -0.47x | CN¥-78.27 Million | CN¥165.58 Million | CN¥243.85 Million | ▼ -1681.0% |
| 2013 | 0.03x | CN¥9.82 Million | CN¥328.37 Million | CN¥318.55 Million | ▲ +101.2% |
| 2012 | -2.52x | CN¥-299.22 Million | CN¥118.91 Million | CN¥418.12 Million | ▲ +63.0% |
| 2011 | -6.81x | CN¥-201.13 Million | CN¥29.55 Million | CN¥230.69 Million | ▼ -2614.0% |
| 2010 | -0.25x | CN¥-11.40 Million | CN¥45.47 Million | CN¥56.87 Million | ▼ -73.6% |
| 2009 | -0.14x | CN¥-6.67 Million | CN¥46.19 Million | CN¥52.86 Million | ▲ +90.2% |
| 2008 | -1.47x | CN¥-81.99 Million | CN¥55.72 Million | CN¥137.71 Million | ▼ -2924.4% |
| 2007 | -0.05x | CN¥-6.71 Million | CN¥138.02 Million | CN¥144.73 Million | — |